Venous Thromboembolic Disease in COVID-19, Pathophysiology, Therapy and Prophylaxis.

Int J Mol Sci · 2022 · PMC9499629 · PMID 36142282

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

borderline significantno p-value reported

The trial showed a statistically significant decrease in the risk of hospitalization with an absolute risk reduction (ARR) of 11.7%, a borderline significant reduction in oxygen supplementation, a non-significant decrease in all causes of mortality, and no indication of harm associated with the treatment.

also in 11,409 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.